Literature DB >> 9260160

Electromyography in myopathy.

R Liguori1, A Fuglsang-Frederiksen, W Nix, P R Fawcett, K Andersen.   

Abstract

Electromyography (EMG) is the most common procedure for screening patients with myopathies and remains the most important technique for assessing the course of the disease over time. Fibrillation potentials, positive sharp waves, myotonic or complex repetitive discharge, as well as polyphasic potentials are non specific and can occur in both myopathic and neurogenic lesions. The most sensitive and specific parameter for myopathy in conventional EMG is the decreased duration of motor unit potentials (MUP), but this can also be seen in disorders of the terminal motor fibers or the neuromuscular junction. More advanced techniques such as single fiber EMG, macro EMG, scanning EMG and turns/amplitude analysis have opened additional possibilities for analysis of the motor unit and the interference pattern, by which both the sensitivity to early changes and specificity for myopathic alterations is increased. The importance of combining different techniques to improve diagnostic yield and specificity is stressed.

Entities:  

Mesh:

Year:  1997        PMID: 9260160     DOI: 10.1016/s0987-7053(97)83775-6

Source DB:  PubMed          Journal:  Neurophysiol Clin        ISSN: 0987-7053            Impact factor:   3.734


  4 in total

1.  Dysphagia in Duchenne muscular dystrophy assessed objectively by surface electromyography.

Authors:  Sally K Archer; Rachel Garrod; Nicholas Hart; Simon Miller
Journal:  Dysphagia       Date:  2012-11-21       Impact factor: 3.438

2.  A correlative study of quantitative EMG and biopsy findings in 31 patients with myopathies.

Authors:  E Dardiotis; E Papathanasiou; I Vonta; G Hadjigeorgiou; E Zamba-Papanicolaou; T Kyriakides
Journal:  Acta Myol       Date:  2011-06

3.  Neurogenic muscle hypertrophy: a case report.

Authors:  Hyun Ho Shin; Young Hoon Jeon; Seung Won Jang; Sae Young Kim
Journal:  Korean J Pain       Date:  2016-09-29

4.  Surface EMG signals in very late-stage of Duchenne muscular dystrophy: a case study.

Authors:  Joan Lobo-Prat; Mariska M H P Janssen; Bart F J M Koopman; Arno H A Stienen; Imelda J M de Groot
Journal:  J Neuroeng Rehabil       Date:  2017-08-29       Impact factor: 4.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.